表紙:ウェアラブル医療機器の世界市場-2023年~2030年
市場調査レポート
商品コード
1352133

ウェアラブル医療機器の世界市場-2023年~2030年

Global Wearable Medical Devices Market - 2023-2030

出版日: | 発行: DataM Intelligence | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.36円
ウェアラブル医療機器の世界市場-2023年~2030年
出版日: 2023年09月27日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

ウェアラブル医療機器(WMD)は、身体に直接装着してバイタルサインをモニターし、データを記録し、治療を施すように設計された医療機器です。これらの機器は、健康指標を追跡し、治療を提供するための手軽で非侵襲的なアプローチを提供するため、ますます人気が高まっています。

医療におけるウェアラブル技術は、視力低下、難聴、障害など、幅広い疾患に対するソリューションを提供しています。外骨格技術のSF的な雰囲気からスマートウォッチのユビキタス性まで、この分野は広大です。

例えば、皮膚に直接貼り付ける電子皮膚パッチは、次世代のウェアラブル・ヘルス技術と考えられています。パッチのセンサーには、臨床医に継続的な遠隔データアクセスを提供する無線送信機が含まれています。電子皮膚パッチは、バイタルサイン・モニタリング、薬物送達、創傷ケア、運動検出などに利用されています。

電子皮膚パッチは、医療提供者が様々な目的で使用することができ、多目的なウェアラブルデバイスとなっています。応用健康科学、健康情報学、薬理学、運動学はすべて、これらの機器を扱うための学問的な方法です。これらの分野の専門家は、電子皮膚パッチ技術の開発、実装、分析にその専門知識を提供することができ、その動向はさらに促進されます。

WMDは通常、デバイス・ハウジング、センサー、通信システムで構成されています。デバイスのハードウェアには通常、制御およびデータ処理用のマイクロプロセッサ、データ保存用のメモリ、電源、BluetoothやWi-Fiなどの通信技術が含まれます。WMDはさらに、体温や呼吸数などのバイタル指標を監視するためのセンサーを追加で搭載することもあります。

さらに、これらのデバイスは、心臓病、糖尿病、高血圧など、さまざまな健康問題を監視するために使用されます。心拍数、血圧、呼吸数などのバイタルサインをモニターし、身体活動や睡眠パターンをモニターし、投薬を行うことができます。さらに、ウェアラブル医療機器における技術進歩の増加、遠隔患者モニタリングや遠隔医療の台頭が、予測期間におけるウェアラブル医療機器の需要を押し上げています。

ダイナミクス

ウェアラブル医療機器の技術進歩が世界のウェアラブル医療機器市場の成長を牽引する見込み

2022年、アップルは新たに発表した腕時計で利用可能な転倒検知技術を導入しました。この傾向はSeries 8でも続いています。シリーズ8では転倒検知技術を採用し、人が転倒したかどうかを識別します。

この技術は常に有効ですが、Series 8ではワークアウトアプリ使用時に最適化されます。つまり、近所を散歩したり、バランス運動を試している高齢者は、ワークアウトプログラムを使って心拍数や歩数を記録するだけでなく、万が一転倒した場合に時計を通じてサポートを受けられるようにすることができます。

転倒検知に加え、シリーズ8は自動車衝突検知機能を搭載し、安全性能を向上させました。同様のテクノロジーを採用したこの時計は、重大な自動車事故が発生する恐れがある場合にユーザーをチェックすることを目的としています。もちろん、これはあらゆる年齢層の人に役立つが、まだ運転している高齢者にとっては、さらに安全性が増すことになります。

また、シリーズ8はオンデマンド心電図機能も備えており、これはシングルリード心電図に匹敵します。読影情報はユーザーのHealthアプリに保存され、必要に応じて次回の診察時にアクセスして共有することができます。

さらに、Series 8とMedicationsアプリを組み合わせることで、複雑な薬剤計画をより簡単に管理できるようになるかもしれません。処方箋や市販薬の服用時間になると、アプリからユーザーの腕時計にメッセージが送信されます。ユーザーは薬を飲んだことを記録し、必要に応じてアプリ上でレジメンを調整することができます。これは多くの高齢者を助けることができる便利なツールです。このように、上記の要因から、予測期間中、市場は拡大すると予想されます。

耳かけ型ウェアラブルデバイスの発売が増加し、世界のウェアラブル医療機器市場の成長を牽引する見込み

2023年6月13日、Stat Health社は、頭部の血流を評価することを目的とした24時間365日稼働の耳かけ型ウェアラブルデバイスを発売し、510万米ドルの予備資金を調達しました。J2 Ventures、BonAngels Venture Partners、幅広いエンジェル投資家グループが同社にスタートアップ資金を提供しました。米国空軍もスタット・ヘルス社に助成金を提供しました。

さらに、ボストンを拠点とするStat Health社は、めまい、脳内霧、偏頭痛、失神、立っているときの倦怠感などの症状の理解を助けるためにウェアラブルを開発しました。COVID-19の後遺症と姿勢起立性頻脈症候群(POTS)は、これらの症状を引き起こす可能性のある2つの頻度の高い疾患です。また、筋痛性脳脊髄炎/慢性疲労症候群(ME/CFS)やその他の起立性疾患の症状であることもあります。さらにスタットヘルス社によると、これらの疾患の症状は、起立時に脳への血流が低下することによって引き起こされます。

同社はジョンズ・ホプキンス大学で臨床試験を行い、2023年3月にJournal of the American College of Cardiology(JACC)で査読を受けました。Stat Health社は、失神を数分前に予測する能力を証明したと主張しています。このように、上記の要因から、予測期間中、市場は拡大すると予想されます。

デジタルヘルスにおけるウェアラブルデバイスの課題が世界のウェアラブル医療機器市場成長の妨げになる見通し

National Center for Biotechnology Information Report 2022によると、Fitbitのデータは心拍数や体温レベルの信号の増加を検出するために利用されています。これらはCOVID-19の可能性のある指標であり、事前に発見することも、より具体的な症状が現れて初めて発見することもできます。

これはウェアラブルの応用の可能性が高いですが、ウェアラブルデータに基づく予測の現状には障害があります。過大評価とは、問題のない状況や異常が体系的に認識されたり、問題があると予測されたりする問題で、ウェアラブルCOVID-19検出アプリケーションに大きな影響を与えます。

さらに、ウェアラブルデータに基づいて、COVID-19、季節性インフルエンザ、および標準的なインフルエンザの症例を区別することはしばしば困難であり、心拍数の上昇は一般的な呼吸器疾患の症状として解釈される可能性があり、その結果、ウェアラブルはCOVID-19感染を誤って検出・予測しています。したがって、上記の要因のために、予測期間中、市場は低迷すると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • ウェアラブル医療機器の技術進歩
      • 耳かけ型ウェアラブルデバイスの発売増加
    • 抑制要因
      • デジタルヘルスにおけるウェアラブルデバイスの課題
    • 機会
      • ウェアラブル医療機器における新興企業の成長
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • アンメットニーズ
  • 規制分析

第6章 COVID-19分析

第7章 ロシア・ウクライナ戦争分析

第8章 デバイスタイプ別

  • 診断機器
    • バイタルサインモニタリング機器
    • 睡眠モニタリング機器
    • 心電計胎児
    • 産科用機器
    • 神経モニタリング装置
    • その他の診断機器
  • 治療機器
    • 疼痛管理機器
    • リハビリテーション機器
    • 呼吸療法機器
    • その他の治療機器

第9章 製品タイプ別

  • 腕時計
  • ヘッドバンド
  • リストバンド
  • イヤーウェア
  • その他

第10章 用途別

  • 心臓の健康
  • 肥満コントロール
  • 糖尿病ケア
  • フィットネス・モニタリング
  • 睡眠トラッキング
  • その他

第11章 エンドユーザー別

  • スポーツ・フィットネス
  • 在宅医療
  • 遠隔患者モニタリング
  • 病院
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 製品ベンチマーク
  • 企業シェア分析
  • 主な発展と戦略

第14章 企業プロファイル

  • Vital Connect
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Apple Inc
  • Fitbit Inc
  • Philips Electronics
  • Garmin Ltd
  • Fossil Group
  • Google Inc
  • Covidien
  • Omron Corp
  • Proteus
  • TomTom International BV
  • Xiaomi Technology Co. Ltd
  • Huawei Technologies Co., Ltd

第15章 付録

目次
Product Code: MD212

Overview

Wearable Medical Devices (WMDs) are medical devices that are designed to be worn directly on the body to monitor vital signs, record data, and give therapies. These devices are becoming increasingly popular because they provide a handy, non-invasive approach to track health indicators and provide therapies.

Wearable technology in healthcare is providing solutions to a wide range of diseases, including vision loss, hearing loss, and disabilities. The sector is vast, ranging from the science-fiction vibe of exoskeleton technology to the ubiquitousness of smartwatches.

For instance, Electronic skin patches, which stick directly to the skin, are seen as the next generation of wearable health technology. Sensors in the patches include wireless transmitters that provide clinicians with continuous remote data access. Electronic skin patches are utilized for vital sign monitoring, medicine delivery, wound care, and motion detection.

Electronic skin patches can be used by healthcare providers for a variety of purposes, making them a versatile wearable device. Applied health sciences, health informatics, pharmacology, and kinesiology are all academic paths to working with these devices. Professionals from these fields can contribute their expertise to the development, implementation, and analysis of electronic skin patch technology, further driving its trend status.

WMDs are typically made up of device housing, sensors, and communication systems. The device hardware typically includes a microprocessor for control and data processing, memory for data storage, power supply, and communication technologies such as Bluetooth and Wi-Fi. WMDs may additionally have extra sensors for monitoring vital indicators like as temperature and breathing rate.

Moreover, these devices are used to monitor a variety of health issues, including heart disease, diabetes, high blood pressure, and more. It can monitor vital signs such as heart rate, blood pressure, and respiratory rate, monitor physical activity and sleep patterns, and provide medication. Furthermore, the increasing technological advancement in wearable medical devices and the rise of remote patient monitoring and telemedicine have driven the demand for wearable medical devices in the forecast period.

Dynamics

Technological Advancement in Wearable Medical Devices is Expected to Drive Global Wearable Medical Device Market Growth

In 2022, Apple introduced fall detection technology available in their newly announced watches. The tendency is continued in Series 8. Series 8 employs fall detection technology to identify whether or not a person has fallen.

This technology is always active, however, it is optimized in the Series 8 when using the workout app. This implies that seniors who are taking a walk around the neighborhood or trying out balance exercises may use the workout program to not only track their heart rate and steps but also to ensure that if they fall, they will be able to receive assistance through their watch.

In addition to fall detection, the Series 8 improves its safety capabilities by including car crash detection. The watch, which employs similar technology, is intended to check on users when it fears a serious vehicle accident. Of course, this is useful for people of all ages, but it adds an extra layer of security for any senior who is still driving.

The Series 8 also has on-demand ECG functionality, which is comparable to a single-lead electrocardiogram. The reading information can be saved on the user's Health app and accessed and shared at their next physician consultation if necessary.

Furthermore, combining the Series 8 with the Medications app might make it much easier to manage a complicated drug plan. When it is time to take prescriptions or over-the-counter meds, the app will send messages to the user's watch. The user can log that they took the meds and adjust the regimen on the app as needed. It's a useful tool that can help a lot of the elderly. Thus, owing to the above factors, the market is expected to drive over the forecast period.

Increasing Launches of Ear Wearable Devices are Expected to Drive Global Wearable Medical Device Market Growth

On June 13, 2023, Stat Health launched a 24/7 in-ear wearable device meant to assess blood flow to the head, with $5.1 million in preliminary funding. J2 Ventures, BonAngels Venture Partners, and a broad group of angel investors provided startup capital to the company. The US Air Force also provided grant support to Stat Health.

Moreover, Boston-based Stat Health created its wearable to aid in the understanding of symptoms such as dizziness, brain fog, migraines, fainting, and weariness when standing. Long COVID and postural orthostatic tachycardia syndrome (POTS) are two frequent conditions that can cause these symptoms. They may also be symptoms of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) or other orthostatic illnesses. Furthermore, according to Stat Health, the symptoms of these disorders are caused by diminished blood flow to the brain when standing.

The company clinically tested its service at Johns Hopkins, and it was peer-reviewed in the Journal of the American College of Cardiology (JACC) in March 2023. Stat Health claimed to have proven the ability to predict fainting minutes in advance. Thus, owing to the above factors, the market is expected to drive over the forecast period.

Challenges for Wearable Devices in Digital Health are Expected to Hamper the Global Wearable Medical Device Market Growth

According to National Center for Biotechnology Information Report 2022, Fitbit data has been utilized to detect increased signals at the level of heart rate and temperature-these are possible indicators of COVID-19 that can be discovered in advance or only when more specific symptoms appear.

This is a highly potential application of wearables, however, the current state of predictions based on wearable data poses obstacles. Overestimation, a problem in which non-problematic situations and anomalies are systematically recognized or forecasted as problematic, has a significant impact on wearable COVID-19 detection applications.

Furthermore, based on wearable data, it is frequently difficult to distinguish between COVID-19, seasonal influenza, and cases of standard influenza-elevated heart rate can be interpreted as a symptom of respiratory illness in general, and as a result, wearables have incorrectly detected and predicted COVID-19 infections. Thus, owing to the above factors, the market is expected to hamper over the forecast period.

Segment Analysis

The global wearable medical devices market is segmented based on device type, product type, application, end user and region.

Owing to the Convenience and Wearability, Accuracy, and Reliability, Integration with Healthcare Systems, Price, and Affordability, the Product Type Segment Accounted for Approximately 23.25% of the Wearable Medical Devices Market Share

Wearable technology allows consumers to measure fitness levels, track whereabouts using GPS, and read text messages more rapidly. Best of all, most of the technologies that enable this are hands-free and portable, eliminating the need to take our devices out of consumer pockets.

Wearables are linked to smart devices, delivering data to them and allowing consumers to view it later as well as in the moment. This might assist consumers in defining objectives and measuring their progress toward them.

Furthermore, the increasing prevalence of chronic diseases, rising product launches and collaborations by the market players, adoption of smartwatches in sports, and advancement in wearable medical watches are the factors expected to drive over the forecast period.

For instance, on November 20, 2022, Digital health start-up H2o Therapeutics received 510(k) marketing clearance from the U.S. Food and Drug Administration for its prescription mobile app Parky for monitoring Parkinson's Disease. Parky App monitors symptoms such as tremors and dyskinesia in real time via the use of the Apple Watch. It is a tool for sharing meaningful and reliable data between patients and medical professionals regarding the course of the disease.

Similarly, Xplore Lifestyle, a Pune-based patient monitoring service provider, introduced a medical-grade smartwatch for continuous cardiac health monitoring. This watch, which claims to be the world's first medical-grade continuous monitoring system in the shape of a watch, was created in collaboration with the Israeli business CardiacSense.

This medical equipment can distinguish between a Normal Heart Rhythm and an Abnormal/Irregular Heart Rhythm (Arrhythmia), particularly Atrial Fibrillation (Afib). It is manufactured in Israel and costs Rs 1 lakh plus taxes.

Additionally, smartwatch innovation is progressing rapidly, driven by advances in sensors, semiconductors, and AI. For example, some smartwatches now feature optical sensors that continuously measure variations in blood volume and composition using a technology called photoplethysmography (PPG). Algorithms produced and continually improved via machine learning use data from these sensors to provide insights into users' activity levels, stress, heart pattern anomalies, and more. Thus, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022, Owing to the Investing in Wearable Technology, Award Recognition, and Technological Advancement in Wearable Medical Devices in the Region

On May 3, 2023, BioIntelliSense, a continuous health monitoring and clinical intelligence company, has been recognized as the "Best Overall Medical Device Company" for 2023 in the 7th annual MedTech Breakthrough Awards program.

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market, selected BioIntelliSense with its BioButton multi-parameter, medical grade wearable device, and advanced clinical intelligence solutions as the 2023 Best Overall Medical Device Company.

The BioIntelliSense comprehensive portfolio of tech-enabled care solutions makes continuous vital sign monitoring efficient, reliable, and cost-effective from in-hospital to home. Its medical grade acute and post-acute solutions empower clinicians with up to 1,440 high-frequency trending measurements per day, versus episodic manually collected vital signs 4-6 times per day, to enable early detection of clinical patient deterioration.

Coupled with the company's advanced data analytics and AlertWatch clinical intelligence engine, this system enables scalable, continuous in-facility and home patient monitoring at a fraction of the cost relative to manually measured traditional care.

Additionally, on April 28, 2023, the Defense Innovation Unit, also known as DIU, in partnership with the private sector, developed a wearable device that was highly successful during the COVID-19 pandemic in identifying infections.

DOD is extending the RATE initiative, which began with the Defence Threat Reduction Agency in 2020, to new user groups following a successful prototype during COVID-19. The DIU's RATE project employs a technologically advanced, predictive artificial intelligence system that was developed utilizing hospital-acquired data from COVID-19-monitored patients. Thus, owing to the above factors, the North American region is expected to hold the largest market share over the forecast period.

Competitive Landscape

The major global players in the market include Vital Connect, Apple Inc, Fitbit Inc, Philips Electronics, Garmin Ltd, Fossil Group, Google Inc, Covidien, Omron Corp, Proteus, TomTom International BV, Xiaomi Technology Co. Ltd, and Huawei Technologies Co., Ltd among others.

COVID-19 Impact Analysis

Wearable medical devices have gained attention during the COVID-19 pandemic for their potential in healthcare. Wearable technology can be used for the early detection of asymptomatic and pre-symptomatic cases of COVID-19.

As COVID-19 expanded, smartwatches that measure blood oxygen saturation (SpO2) were more commonly available, alerting people with low SpO2-a potentially fatal indication that is difficult to identify on one's own.

More than 10% of smartwatch owners in the United States are now utilizing them to detect COVID-19 symptoms. The pandemic may have even boosted smartwatch sales: 15% of US consumers who own a smartwatch purchased it following the outbreak of COVID-19.

Additionally, Wearable sensors that monitor heart rate, skin temperature, and respiratory rate have shown promise in detecting COVID-19. These sensors can track presymptomatic and asymptomatic infections, aiming to decrease the spread of COVID-19.

Also, Healthcare apps can be used to monitor the spread of COVID-19 and gather vital measurements such as pulse, temperature, and sleep duration from users. For instance, in 2021, the Robert Koch Institute partnered with a healthcare start-up to launch an app named Corona Data Donation that gathers vital measurements from users and analyzes whether they are symptomatic of COVID-19.

In contrast, getting healthcare providers to use wearable devices is challenging as healthcare is a highly regulated industry and is slow to adopt new technologies. The majority of healthcare providers are skeptical about the accuracy and reliability of wearable devices.

Also, poor or over-optimistic accuracy results may undermine the applicability of wearable technology in real-world settings. Thus, owing to the above factors, the pandemic had a moderate impact and is expected to improve gradually over the forecast period.

By Product Type

  • Diagnostic Devices
    • Vital Sign Monitoring Devices
    • Sleep Monitoring Devices
    • Electrocardiographs Fetal
    • Obstetric Devices
    • Neuromonitoring Devices
    • Other diagnostic devices
  • Therapeutic devices
    • Pain Management Devices
    • Rehabilitation Devices
    • Respiratory Therapy Devices
    • Other Therapeutic Devices

By Product Type

  • Watch
  • Headband
  • Wristband
  • Ear Wear
  • Others

By Application

  • Cardiac health
  • Obesity control
  • Diabetes care
  • Fitness monitoring
  • Sleep tracking
  • Others

By End User

  • Sports and Fitness
  • Home Healthcare
  • Remote Patient Monitoring
  • Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On August 3, 2022, GOQii introduced Smart Vital Ultra and GOQii Stream devices targeted at young adults and youth, encouraging them to lead healthy and active lifestyles. GOQii is also launching a feather-light and water-resistant device, GOQii Stream that allows a user to make and receive calls via Bluetooth and a built-in speaker and microphone. It features a dial pad, an option to access recent calls, and sync phone contacts. This upcoming device (GOQii Stream) can be booked at GOQii Webstore and e-commerce platforms like Amazon India and Flipkart.
  • On December 12, 2022, Frost & Sullivan awarded VitalConnect the 2022 North America New Product Innovation Award based on its latest evaluation of the wearable biosensor business for developing a world-class biosensor that comfortably monitors patients and diagnoses several health concerns. VitalConnect greatly lowered hospital workloads by allowing patients who wish to move freely or can be monitored at home to utilize comfortable, cutting-edge cardiac monitoring equipment with the same efficacy and quality as a hospital or home-based device.
  • On September 27, 2022, Google Cloud and Fitbit Health Solutions introduced the Device Connect for Fitbit solution, which intends to provide healthcare organizations with a more holistic view of patients outside of clinical settings by utilizing data from wearable devices. Participating health systems will get access to consenting patients' wearable data via the Fitbit Web API, which will allow consumers to select what data they share. The data, which includes temperature, heart rate, oxygen levels, sleep, stress, and activity, is then filtered through a data connection with automated normalization and standardization capabilities for analytics via Google Cloud BigQuery. From there, health systems can create and customize analytics dashboards and artificial intelligence models.

Why Purchase the Report?

  • To visualize the global wearable medical devices market segmentation based on the device type, product type, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of wearable medical devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global wearable medical devices market report would provide approximately 69 tables, 70 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Product Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological Advancement in Wearable Medical Devices
      • 4.1.1.2. Increasing Launches of Ear Wearable Devices
    • 4.1.2. Restraints
      • 4.1.2.1. Challenges for Wearable Devices in Digital Health
    • 4.1.3. Opportunity
      • 4.1.3.1. The Growing Startups in Wearable Medical Devices
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Device Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 8.1.2. Market Attractiveness Index, By Device Type
  • 8.2. Diagnostic Devices*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Vital Sign Monitoring Devices
    • 8.2.4. Sleep Monitoring Devices
    • 8.2.5. Electrocardiographs Fetal
    • 8.2.6. Obstetric Devices
    • 8.2.7. Neuromonitoring Devices
    • 8.2.8. Other diagnostic devices
  • 8.3. Therapeutic Devices
    • 8.3.1. Pain Management Devices
    • 8.3.2. Rehabilitation Devices
    • 8.3.3. Respiratory Therapy Devices
    • 8.3.4. Other Therapeutic Devices

9. By Product Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.1.2. Market Attractiveness Index, By Product Type
  • 9.2. Watch*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Headband
  • 9.4. Wristband
  • 9.5. Ear Wear
  • 9.6. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Cardiac health*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Obesity control
  • 10.4. Diabetes care
  • 10.5. Fitness monitoring
  • 10.6. Sleep tracking
  • 10.7. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Sports and Fitness*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Home Healthcare
  • 11.4. Remote Patient Monitoring
  • 11.5. Hospitals
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.7.1. U.S.
      • 12.2.7.2. Canada
      • 12.2.7.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.7.1. Germany
      • 12.3.7.2. U.K.
      • 12.3.7.3. France
      • 12.3.7.4. Italy
      • 12.3.7.5. Spain
      • 12.3.7.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.7.1. Brazil
      • 12.4.7.2. Argentina
      • 12.4.7.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.7.1. China
      • 12.5.7.2. India
      • 12.5.7.3. Japan
      • 12.5.7.4. Australia
      • 12.5.7.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Product Benchmarking
  • 13.3. Company Share Analysis
  • 13.4. Key Developments and Strategies

14. Company Profiles

  • 14.1. Vital Connect*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Apple Inc
  • 14.3. Fitbit Inc
  • 14.4. Philips Electronics
  • 14.5. Garmin Ltd
  • 14.6. Fossil Group
  • 14.7. Google Inc
  • 14.8. Covidien
  • 14.9. Omron Corp
  • 14.10. Proteus
  • 14.11. TomTom International BV
  • 14.12. Xiaomi Technology Co. Ltd
  • 14.13. Huawei Technologies Co., Ltd

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us